Published in J Virol on November 01, 1997
A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques. J Virol (2003) 1.41
Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol (1999) 1.36
Absence of perforin expression confers axonal protection despite demyelination. Neurobiol Dis (2006) 1.26
High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus. J Virol (2001) 1.10
Virus-induced demyelination in nude mice is mediated by gamma delta T cells. Am J Pathol (2002) 0.97
Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases. Genetics (2007) 0.95
Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection. J Virol (2002) 0.95
Porcine encephalomyocarditis virus persists in pig myocardium and infects human myocardial cells. J Virol (2001) 0.91
Complementary contribution of CD4 and CD8 T lymphocytes to T-cell infiltration of the intact and the degenerative spinal cord. Am J Pathol (2005) 0.91
Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection. Brain Behav Immun (2007) 0.90
Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J Virol (1999) 0.90
Neonatal maternal separation alters immune, endocrine, and behavioral responses to acute Theiler's virus infection in adult mice. Behav Genet (2010) 0.88
Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficits. Eur J Immunol (2002) 0.85
Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease. J Virol (2004) 0.85
Glucocorticoid exposure alters the pathogenesis of Theiler's murine encephalomyelitis virus during acute infection. Physiol Behav (2008) 0.82
Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption. J Neurovirol (2013) 0.81
Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination. Virology (2006) 0.79
Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice: II. CNS disease severity. J Neuroimmunol (2010) 0.78
Human HLA-DR transgenes protect mice from fatal virus-induced encephalomyelitis and chronic demyelination. J Virol (2008) 0.77
Quantitative trait loci analysis reveals candidate genes implicated in regulating functional deficit and CNS vascular permeability in CD8 T cell-initiated blood-brain barrier disruption. BMC Genomics (2013) 0.76
Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection. J Virol (2013) 0.76
Pathogenesis of coxsackievirus-B5 acquired from intra-renal porcine islet cell xenografts in diabetic mice. Xenotransplantation (2009) 0.75
Social disruption alters pain and cognition in an animal model of multiple sclerosis. J Neuroimmunol (2015) 0.75
Human class I major histocompatibility complex alleles determine central nervous system injury versus repair. J Neuroinflammation (2016) 0.75
IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol (1980) 10.30
SPONTANEOUS ENCEPHALOMYELITIS OF MICE--A NEW VIRUS DISEASE. Science (1934) 9.02
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun (1975) 7.12
Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature (1985) 4.22
Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest (1975) 3.45
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology (1988) 3.17
Theiler's virus persists in glial cells during demyelinating disease. Cell (1981) 2.67
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol (1983) 2.60
Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog (1987) 2.56
Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18
Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity. J Immunol (1985) 2.06
The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol (1995) 2.06
Theiler's virus infection of beta 2-microglobulin-deficient mice. J Virol (1993) 2.04
Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice. Virology (1985) 2.04
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology (1990) 1.90
Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol (1981) 1.87
Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J Immunol (1993) 1.85
Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J Virol (1990) 1.82
Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pathol (1982) 1.81
Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol (1988) 1.72
Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol (1987) 1.65
Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology (1984) 1.62
DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann Neurol (1984) 1.62
Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat Genet (1993) 1.61
The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol (1982) 1.57
Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest (1986) 1.53
Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur J Immunol (1993) 1.53
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
Role of macrophages during Theiler's virus infection. J Virol (1997) 1.52
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest (1983) 1.34
Theiler's virus replication in brain macrophages cultured in vitro. J Virol (1992) 1.30
Determinants of persistence and demyelination of the DA strain of Theiler's virus are found only in the VP1 gene. J Virol (1991) 1.27
Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol (1996) 1.23
The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J Gen Virol (1992) 1.13
Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J Virol (1992) 1.11
Quantitation, with a new assay, of Theiler's virus capsid protein in the central nervous system of mice. J Virol (1986) 1.07
Virus-induced demyelination in mice: "dying back" of oligodendrocytes. Mayo Clin Proc (1985) 1.05
Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol (1994) 1.05
Theiler's virus in brain cell cultures: lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages. J Neurosci Res (1986) 1.04
Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. J Virol (1991) 1.03
Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus. J Virol (1995) 1.03
The balance between persistent virus infection and immune cells determines demyelination. J Immunol (1996) 0.98
Maintenance of immunocytologically identified Purkinje cells from mouse cerebellum in monolayer culture. Brain Res (1984) 0.96
Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation. J Neuroimmunol (1990) 0.96
Spontaneous CNS remyelination in beta 2 microglobulin-deficient mice following virus-induced demyelination. J Neurosci (1995) 0.94
The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells. J Virol (1995) 0.92
The pathogenesis of Theiler's GD VII encephalomyelitis virus infection in mice as studied by immunofluorescent technique and infectivity titrations. J Immunol (1967) 0.92
Chimeric Theiler's virus with altered tropism for the central nervous system. J Virol (1994) 0.91
Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res (1996) 0.90
Infection of class II-deficient mice by the DA strain of Theiler's virus. J Virol (1996) 0.86
Cytotropism of Theiler's murine encephalomyelitis viruses in oligodendrocyte-enriched cultures. Arch Virol (1990) 0.81
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (1989) 23.74
Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques (1990) 13.62
Multiple sclerosis. N Engl J Med (2000) 12.69
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20
Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet (1998) 6.09
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Gene splicing by overlap extension. Methods Enzymol (1993) 4.59
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science (1998) 3.64
Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol (1992) 3.53
Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis (2001) 3.42
Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol (2012) 2.96
Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet (1992) 2.69
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
A mutation in the voltage-gated sodium channel gene associated with pyrethroid resistance in Latin American Aedes aegypti. Insect Mol Biol (2007) 2.60
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol (1983) 2.60
Spontaneous H-2 mutants provide evidence that a copy mechanism analogous to gene conversion generates polymorphism in the major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 2.51
Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci (1997) 2.44
Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN. Neurology (1998) 2.38
Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J Immunol (1984) 2.35
Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax (1998) 2.33
Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology (1998) 2.26
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med (1997) 2.19
Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
White-light filaments for atmospheric analysis. Science (2003) 2.07
Regulating the interpersonal self: strategic self-regulation for coping with rejection sensitivity. J Pers Soc Psychol (2000) 2.05
Positive selection of transgenic receptor-bearing thymocytes by Kb antigen is altered by Kb mutations that involve peptide binding. Proc Natl Acad Sci U S A (1990) 2.05
Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem (1994) 2.04
Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol (1985) 1.98
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci U S A (1994) 1.94
Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys (1994) 1.94
Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences. Proc Natl Acad Sci U S A (1983) 1.92
Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science (1982) 1.88
Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med (1989) 1.83
Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci (1998) 1.78
Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology (1995) 1.76
The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain (2001) 1.70
In vitro recombination and mutagenesis by overlap extension PCR. Methods Mol Biol (1996) 1.69
Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci U S A (1997) 1.67
A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology (1990) 1.66
Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int (2007) 1.65
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63
Antimitochondrial antibodies in jaundice following drug administration. JAMA (1969) 1.61
Okadaic acid, a protein phosphatase inhibitor, blocks calcium changes, gene expression, and cell death induced by gibberellin in wheat aleurone cells. Plant Cell (1996) 1.56
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology (2003) 1.56
Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin. Eur J Neurol (2010) 1.55
Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology (1986) 1.55
Engineering a homo-ethanol pathway in Escherichia coli: increased glycolytic flux and levels of expression of glycolytic genes during xylose fermentation. J Bacteriol (2001) 1.55
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. Mayo Clin Proc (1992) 1.53
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int (2007) 1.53
Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology (2004) 1.51
Interaction between Kb and Q4 gene sequences generates the Kbm6 mutation. Mol Cell Biol (1986) 1.50
Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J Virol (1991) 1.50
Teaching community-oriented primary care through longitudinal group projects. Fam Med (1998) 1.50
Development of a highly sensitive galvanic cell oxygen sensor. Talanta (1995) 1.49
Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol (1989) 1.49
Identification of the cloned gene for the murine transplantation antigen H-2Kb by hybridization with synthetic oligonucleotides. Mol Cell Biol (1983) 1.48
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.46
The influence of acute and chronic hypercalcemia on the parathyroid hormone response to hypocalcemia in rabbits. Eur J Endocrinol (2002) 1.44
Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol (1992) 1.44
Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Acta Cytol (1999) 1.43
Human T-cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis. Mayo Clin Proc (1991) 1.43
Favorable strategy for the ostial lesion of the left anterior descending coronary artery: influence on narrowing of circumflex coronary artery. Cathet Cardiovasc Diagn (1998) 1.42
Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program. Am J Clin Nutr (1980) 1.40
Determining appropriate small vessels for stenting by intravascular ultrasound. J Invasive Cardiol (2000) 1.39
An ideR mutant of Mycobacterium smegmatis has derepressed siderophore production and an altered oxidative-stress response. Mol Microbiol (1996) 1.39
The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1999) 1.38
[Is aggressiveness really inhibited in asthmatic adolescents? An epidemiological approach]. Rev Mal Respir (2001) 1.38
Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). Am J Pathol (1983) 1.37
Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2002) 1.35
Mapping class I gene sequences in the major histocompatibility complex. Nature (1982) 1.35
Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest (1983) 1.34
Literacy promotion for Hispanic families in a primary care setting: a randomized, controlled trial. Pediatrics (1999) 1.33
Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer (2012) 1.32
Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology (2004) 1.30
YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-kappa B during acute-phase response. Mol Cell Biol (1994) 1.28
Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat (2008) 1.27
Viral perturbation of endocrine function: disordered cell function leads to disturbed homeostasis and disease. Nature (1984) 1.27
CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol (1998) 1.27
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology (2005) 1.26
Structural mutation affecting intracellular transport and cell surface expression of murine class II molecules. J Exp Med (1988) 1.26
A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J Exp Med (1996) 1.25
Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest (1986) 1.24
Retinocochleocerebral vasculopathy. Medicine (Baltimore) (1998) 1.23
Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol (1996) 1.23